INVO Fertility (NASDAQ:IVF) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $(0.65) by 153.85 percent. This is a 100.11 percent increase over losses of $(318.00) per share from the same period last year. The company reported quarterly sales of $2.175 million which missed the analyst consensus estimate of $2.709 million by 19.71 percent. This is a 16.75 percent increase over sales of $1.863 million the same period last year.